Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2623 (LINC02623) is a human long non-coding RNA gene, classified as a long intergenic non-coding RNA (lincRNA), meaning it is transcribed from a region of the genome that does not overlap with protein-coding genes. General lincRNA functions include regulation of gene expression, acting as molecular scaffolds or decoys, and participation in chromatin modification and various cellular processes. However, LINC02623 itself does not have well-characterized biological functions or established links to disease, and it is not recognized as a therapeutic target or biomarker in current biomedical resources.
Not applicable; there are no drugs targeting LINC02623, and mechanistic drug interactions are not described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2623 (LINC02623).